Which blood thinner is safer for clots? small study aims to find out
NCT ID NCT02559856
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compared two common blood thinners, rivaroxaban and apixaban, in 72 adults with newly diagnosed blood clots in the legs or lungs. The main goal was to see if a larger trial is possible by checking how many patients could join and complete follow-ups. Researchers also tracked bleeding events and clot recurrences to assess safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hamilton General Hospital
Hamilton, Ontario, L8L 2X2, Canada
-
Hôtel-Dieu de Sherbrooke
Sherbrooke, Quebec, J1G 2E8, Canada
-
The Ottawa Hospital - General Campus
Ottawa, Ontario, K1H 8L6, Canada
-
University of Alberta
Edmonton, Alberta, T6G 2G3, Canada